Pharmacology
Help for Sarcoidosis-Related Fatigue
Fed Pract. 2013 April;30(4):e2
More than half of sarcoidosis patients say fatigue is debilitating, and most studies of sarcoidosis identify fatigue as a major cause of impaired quality of life. Armodafinil significantly reduces fatigue in patients with sarcoidosis, according to a small study by researchers from the University of Cincinnati in Cincinnati, Ohio, and Harvard Medical School in Boston, Massachusetts.